Keros Therapeutics Inc.

NASDAQ: KROS · Real-Time Price · USD
14.41
0.45 (3.22%)
At close: Aug 14, 2025, 3:59 PM
14.42
0.07%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Keros Therapeutics Revenue

Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending June 30, 2025, Keros Therapeutics generated $18.17M in revenue.
Revenue (ttm)
3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
21.78K
Employees
163
Market Cap
585.27M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.